Table 1.
Subject demographic characteristics.
| Schizophrenia Patients (N = 153) | Healthy Controls (N = 125) | p-Value | |
|---|---|---|---|
| Mean Age | 32.35 ± 1.00 | 30.83 ± 1.03 | 0.29 |
| Sex | 0.16 | ||
| Male | 103 | 74 | |
| Female | 50 | 51 | |
| Race | 0.28 | ||
| White | 93 | 86 | |
| Black/African American | 52 | 34 | |
| Other | 8 | 5 | |
| Mean Parental Education | 13.88 ± 0.28 | 14.53 ± 0.19 | 0.05 |
| Mean Age at Onset of Illness | 21.08 ± 0.47 | -- | -- |
| Mean Duration of Illness | 10.34 ± 1.19 | -- | -- |
| Mean Chlorpromazine Equivalent | 468.46 ± 26.48 | -- | -- |
| Mean PANSS Score | |||
| Positive Subscale | 18.35 ± 0.54 | -- | -- |
| Negative Subscale | 16.15 ± 0.61 | -- | -- |
| General Subscale | 32.15 ± 0.67 | -- | -- |
* significant at α=0.05 level